Skip to content

Author

Jia-Xu Hong

We have 3 of 32 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Nanomicelles self-assembled using cyclosporine A-hyaluronic acid conjugates for dry eye disease treatment.

Dry eye disease is a chronic inflammatory disorder of the ocular surface in which tear film instability and hyperosmolarity perpetuate a self-sustaining cycle of epithelial damage and inflammation; however, the therapeutic efficacy of topical cyclosporine A (CsA), a mainstay of treatment, is severely limited by rapid t...

Zhen-Yi Lin, Ming-Rui Cheng, Hao-Nan Cui et al. · 0 citations
Sep 2026

Mucoadhesive recombinant human catalase for dry eye disease: From protein engineering to first-in-human study.

BACKGROUND Oxidative stress caused by excess reactive oxygen species (ROS) plays a key role in the progression of dry eye disease (DED), yet no approved DED therapy directly eliminates ROS. Here, we develop an antioxidant biologic with enhanced ocular-surface retention by thiol engineering of recombinant human catalase...

Ming Shao, Yi-Teng Lu, Wen-Jie Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.